Exchange: NYSEMkt·Updated 01:22 PM EDT
RGNT logo

RGNTRegentis Biomaterials

$3.98
$0.17
(4.10%)
Today
Mkt Cap$21.49M
Vol115,731.00
News
all
press releases
News Placeholder
Why Did RGNT Stock Surge More Than 850% Today?
Regentis Biomaterials filed a notice to withdraw its Form F-1 registration statement, indicating that it did not wish to proceed with a proposed public offering announced last month.
Stocktwits
News Placeholder
Why Traders Are Piling into These Emerging Healthcare Names as New Catalysts Emerge
Biotechnology and healthcare innovation dominated investor conversations today as multiple companies delivered meaningful corporate, clinical, regulatory, and commercialization updates. From artificial intelligence-powered drug discovery platforms to neuro-oncology, regenerative medicine, wound care technologies, and autoimmune disease therapies, investors focused on companies that could potentially benefit from major industry trends while advancing important milestones of their own. $CUPR, $HYFT, $NTHI, $RGNT, $GELS, $SABS
24-7 Market News
News Placeholder
These Emerging Innovators Are Making Big Moves
From record-setting spider silk production and regenerative medicine commercialization efforts to next-generation battery technology and AI infrastructure expansion, a diverse group of companies is demonstrating how breakthrough technologies are beginning to transition from concept to commercialization. $KBLB, $RGNT, $ADTX, $GMEX, $FAC, $STAK
24-7 Market News
News Placeholder
Nano-Cap Regentis Biomaterials Stock Is Up Nearly 15% This Year: Why Retail Traders Are Swarming It
Heading to close this week as its best week since IPO, RGNT has become a retail favorite with surging followers on Stocktwits.
Stocktwits
<
...
1
>

Advertisement|Remove ads.